首頁 > 市場調查報告書 > 醫療設備

麻醉

市場調查報告書

商品編碼

1904818

吸入麻醉劑市場規模、佔有率及成長分析（按藥物、應用和地區分類）－2026-2033年產業預測

Inhalation Anesthesia Market Size, Share, and Growth Analysis, By Drug (Sevoflurane, Desflurane), By End-Use (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 200 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，吸入麻醉劑市場規模將達到 17.5 億美元，到 2025 年將達到 19.1 億美元，到 2033 年將達到 39.3 億美元，在預測期（2026-2033 年）內複合年成長率為 9.4%。

吸入麻醉市場預計將迎來顯著成長，這主要得益於慢性病盛行率上升和醫療機構需求不斷成長。全球外科手術數量的激增進一步推動了這一成長，凸顯了對吸入麻醉解決方案的持續需求。麻醉劑研發的技術進步以及對創新技術投資的不斷增加，為市場參與者開闢了新的機會。此外，人口老化和對兒童專業麻醉需求的不斷成長預計將推動市場的長期擴張。然而，潛在的健康風險、合格麻醉醫師的短缺以及先進麻醉輸送系統的高成本等挑戰，可能會抑制未來對吸入麻醉產品的需求。

吸入麻醉市場促進因素

隨著全球手術數量的增加，慢性疾病的增加推動了對吸入麻醉的需求。手術介入日益頻繁，麻醉在確保患者術中安全和舒適方面發揮著至關重要的作用，這將為市場帶來新的成長機會。對有效麻醉解決方案日益成長的需求表明，隨著醫療機構致力於改善手術效果和整體患者照護，吸入麻醉具有巨大的成長潛力。因此，吸入麻醉有望吸引更多關注，從而為市場發展創造有利環境。

吸入麻醉市場的限制

接受過吸入麻醉訓練的麻醉醫師數量有限，某些地區的短缺情況可能更為嚴重。缺乏能有效實施吸入麻醉的合格人員，對市場成長前景構成重大挑戰。隨著麻醉服務需求的持續成長，熟練醫務人員的短缺可能會阻礙市場的發展和擴張。解決這個人才短缺問題對於充分發揮吸入麻醉的創新和廣泛應用潛力至關重要，最終有助於避免對市場動態負面影響。

吸入麻醉市場趨勢

隨著醫療機構日益重視環保實踐，對永續麻醉劑的需求不斷成長，正推動吸入麻醉劑市場持續成長。為此，製造商正積極創新，研發對環境影響最小的麻醉劑，以回應全球永續性舉措。這項轉變不僅符合監管要求，也吸引了致力於減少碳足跡的醫療機構的注意。隨著醫療機構環保意識的不斷增強，投資永續解決方案的公司有望在市場中脫穎而出，獲得競爭優勢，同時兼顧病患安全和環境保護的雙重目標。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Baxter International Inc.（USA）
Halocarbon Products Corporation（USA）
Piramal Critical Care（India）
AbbVie Inc.（USA）
Fresenius Kabi AG（Germany）
GE Healthcare（USA）
Hikma Pharmaceuticals PLC（UK）
Linde Plc（Ireland）
Dragerwerk AG & Co. KGaA（Germany）
Mindray Medical International Limited（China）
Shenzhen Landwind Industry Co., Ltd.（China）
Medtronic Plc（Ireland）
Medtronic Plc（Ireland）
Smith's Group plc（UK）
Teleflex Incorporated（USA）
Masimo Corporation（USA）
Penlon Ltd.（UK）
Dameca A/S（Denmark）
Soma Technology, Inc.（USA）
Narang Medical Limited（India）

簡介目錄

Product Code: SQMIG35B2217

Inhalation Anesthesia Market size was valued at USD 1.75 Billion in 2024 and is poised to grow from USD 1.91 Billion in 2025 to USD 3.93 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The inhalation anesthesia market is poised for significant growth driven by the rising prevalence of chronic diseases and increased demand within healthcare facilities. This growth is further fueled by a surge in surgical procedures globally, highlighting a consistent need for inhalation anesthesia solutions. Technological advancements in anesthetic development and expanded investments in innovative techniques are opening new avenues for market players. Additionally, an aging population and the increasing need for specialized pediatric anesthesia are expected to enhance market expansion over time. However, challenges such as potential health risks, a shortage of qualified anesthesiologists, and the high costs associated with advanced anesthesia delivery systems may dampen future demand for inhalation anesthesia products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Inhalation Anesthesia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Inhalation Anesthesia Market Segments Analysis

Global Inhalation Anesthesia Market is segmented by Drug, Application End Use and region. Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Induction, and Maintenance. Based on End-Use, the market is segmented into Hospitals,Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Inhalation Anesthesia Market

The increasing prevalence of chronic diseases has led to a rise in surgical procedures globally, driving the demand for inhalation anesthesia. As surgical interventions become more frequent, the essential function of anesthesia in ensuring patient safety and comfort during these procedures will open up new avenues for growth within the market. This heightened need for effective anesthetic solutions signifies a robust expansion potential for inhalation anesthesia, as healthcare providers seek to enhance surgical outcomes and improve overall patient care. Consequently, the spotlight on inhalation anesthesia will likely intensify, creating favorable conditions for market advancements.

Restraints in the Inhalation Anesthesia Market

The availability of trained anesthesiologists specializing in the administration of inhalation anesthesia is limited, and in certain regions, this shortage may be worsening. The lack of qualified professionals capable of effectively managing inhalation anesthesia poses a significant challenge to the market's growth prospects. As the demand for anesthesia services continues to rise, the insufficient pool of skilled practitioners could hinder advancements and expansion within the market. Addressing this workforce gap is essential to ensure that the potential for innovation and broader application of inhalation anesthesia is fully realized, ultimately impacting overall market dynamics negatively.

Market Trends of the Inhalation Anesthesia Market

The inhalation anesthesia market is increasingly driven by a growing demand for sustainable anesthetic agents, as healthcare providers prioritize environmentally friendly practices. Manufacturers are responding by innovating and formulating anesthetics that have minimal ecological impact, aligning with global sustainability initiatives. This shift not only meets the regulatory requirements but also appeals to institutions committed to reducing their carbon footprint. As eco-consciousness continues to gain traction in medical settings, companies that invest in sustainable solutions are poised to differentiate themselves and gain a competitive edge in the market, catering to the dual objectives of patient safety and environmental stewardship.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Case Study Analysis
Regulatory Landscape
Technology Analysis

Inhalation Anesthesia Market, By Drug

Market Overview
Sevoflurane
Desflurane
Isoflurane
Others

Inhalation Anesthesia Market, By Application

Market Overview
Induction
Maintenance

Inhalation Anesthesia Market, By End-Use

Market Overview
Hospitals
Ambulatory Surgical Centers
Others

Healthcare Analytical Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halocarbon Products Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Critical Care (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Linde Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Landwind Industry Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith's Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Masimo Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penlon Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dameca A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soma Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Narang Medical Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments